Vol. 21 No. 1 (2011): Psychiatry and Clinical Psychopharmacology

Published: 2021-02-26

Reviews

Treatment of patients with schizophrenia and comorbid substance use disorders

Nesrin Dilbaz, Aslı Enez Darçın

(80-90)

DOI: https://doi.org/10.5350/KPB-BCP201121114
Full Text PDF Abstract

Trace amines and their relevance to psychiatry and neurology: a brief overview

Deepak Narang, Sara Tomlinson, Andrew Holt, Darrell D. Mousseau, Glen B. Baker

(73-79)

DOI: https://doi.org/10.5350/KPB-BCP201121113
Full Text PDF Abstract

Therapeutic goals, clinical indicators and follow up in major depressive disorder

Omer Aydemir

(S1-S9)

Full Text PDF Abstract

Comparison of immediate release and extended release formulations in therapy

Yağız Üresin, Elif Baran

(S27-S32)

Full Text PDF Abstract

Management of inadequate response in major depressive disorder and new treatment options

Oğuz Karamustafalıoğlu, Burcu Goksan Yavuz

(S20-S25)

Full Text PDF Abstract

Unmet needs in treatment of depression: comorbid anxiety and management

Nesrin Dilbaz, Aslı Enez Darçın, Serçin Yalçın Çavuş

(S10-S19)

Full Text PDF Abstract

Original Papers

Risperidone treatment in preschool children with disruptive behavior disorders: a chart review study

Murat Coskun, Suleyman Salih Zoroglu, Mucahit Ozturk

(33-41)

DOI: https://doi.org/10.5350/KPB-BCP201121106
Full Text PDF Abstract

Poison information center data about druginduced acute dystonic reactions

M. Aylin Arici, Durgul Ozdemir, Kubilay Oransay, Sinem Evcim, Yesim Tuncok, Sule Kalkan

(58-63)

DOI: https://doi.org/10.5350/KPB-BCP201121109
Full Text PDF Abstract

Metabolic syndrome and depressive symptoms in a primary health care setting in Turkey

Hakan Demirci, Yildirim Cinar, Nazan Bilgel

(49-57)

DOI: https://doi.org/10.5350/KPB-BCP201121108
Full Text PDF Abstract

P50 sensory gating in children and adolescents with ADHD and effects of methylphenidate administration on P50 sensory gating

Ibrahim Durukan, Mehmet Yucel, Murat Erdem, Koray Kara, Oguzhan Oz, Dursun Karaman, Zeki Odabasi

(42-48)

DOI: https://doi.org/10.5350/KPB-BCP201121107
Full Text PDF Abstract

Effects of catechol-O-methyltransferase enzyme Val158Met polymorphism on cognitive functions in schizophrenic patients

Gulfizar Sozeri Varma, Filiz Karadag, M. Emin Erdal, Özlem İzci Ay, Neslihan Levent, Çiğdem Tekkanat, Tuba Edgünlü Gökdoğan, Hasan Herken

(24-32)

DOI: https://doi.org/10.5350/KPB-BCP201121105
Full Text PDF Abstract

The efficacy of venlafaxine in treatment of depression in Parkinson`s disease

Fuat Torun, Kemal Bayulkem, Sebahat Dilek Torun

(18-23)

DOI: https://doi.org/10.5350/KPB-BCP201121104
Full Text PDF Abstract

The effects of reboxetine and venlafaxine on ECG variables in depressed patients

Salih Saygin Eker, Cengiz Akkaya, Sengul Cangul, Ugur Yuvanc, Selcuk Kırlı, Asli Sarandol

(11-17)

DOI: https://doi.org/10.5350/KPB-BCP201121103
Full Text PDF Abstract

Case Report

A case report of acute dystonia caused by a therapeutic dose of metoclopramide

Nuray Can Uluğ, Mehmet Uluğ

(70-72)

DOI: https://doi.org/10.5350/KPB-BCP201121112
Full Text PDF Abstract

Suicide attempt with a very high dose of quetiapine

Alptekin Çetin, Numan Konuk

(67-69)

DOI: https://doi.org/10.5350/KPB-BCP201121111
Full Text PDF Abstract

Pregabalin abuse: a case report

Ilhan Yargic, Filiz Alyanak Ozdemiroglu

(64-66)

DOI: https://doi.org/10.5350/KPB-BCP201121110
Full Text PDF Abstract

EDITORIAL

Depression and cardiovascular disease: the need for improved case definition

Jorge Perez Parada

(7-10)

DOI: https://doi.org/10.5350/KPB-BCP201121102
Full Text PDF Abstract

Beyond the glutamate N-methyl D-aspartate receptor in major depressive disorder: the mTOR signaling pathway

Beata Karolewicz, Mesut Cetin, Feyza Aricioglu

(1-6)

DOI: https://doi.org/10.5350/KPB-BCP201121101
Full Text PDF Abstract